1. bookVolume 1 (2017): Issue s1 (October 2017)
    EBTNA Utility Gene Test on Ophthalmology
Journal Details
License
Format
Journal
eISSN
2564-615X
First Published
30 Jan 2017
Publication timeframe
4 times per year
Languages
English
access type Open Access

Genetic testing for Doyne honeycomb retinal dystrophy

Published Online: 27 Oct 2017
Volume & Issue: Volume 1 (2017) - Issue s1 (October 2017) - EBTNA Utility Gene Test on Ophthalmology
Page range: 45 - 47
Journal Details
License
Format
Journal
eISSN
2564-615X
First Published
30 Jan 2017
Publication timeframe
4 times per year
Languages
English
Abstract

We studied the scientific literature and disease guidelines in order to summarize the clinical utility of genetic testing for Doyne honeycomb retinal dystrophy (DHRD). The disease has an autosomal dominant inheritance and is caused by variations in the EFEMP1 gene. There is insufficient data to establish the prevalence of DHRD. Clinical diagnosis is based on clinical findings, ophthalmological examination, electroretinography, fluorescein angiography and optical coherence tomography. The genetic test is useful for confirming diagnosis, and for differential diagnosis, couple risk assessment and access to clinical trials.

1. Gregory CY, Evans K, Wijesuriya SD, Kermani S, Jay MR, Plant C, et al. The gene responsible for autosomal dominant Doyne’s honeycomb retinal dystrophy (DHRD) maps to chromosome 2p16. Hum Mol Genet. 1996 Jul;5(7):1055-9. PubMed PMID: 8817347.10.1093/hmg/5.7.10558817347Search in Google Scholar

2. Piguet B, Haimovici R, Bird AC. Dominantly inherited drusen represent more than one disorder: a historical review. Eye (Lond). 1995;9 ( Pt 1):34-41. PubMed PMID: 7713248.10.1038/eye.1995.57713248Search in Google Scholar

3. Zech JC, Zaouche S, Mourier F, Placuchu H, Grange JD, Trepsat C. Macular dystrophy of malattia leventinese. A 25 year follow up. Br J Ophthalmol. 1999 Oct;83(10):1195-6. PubMed PMID: 10636647; PubMed Central PMCID: PMC1722836.10.1136/bjo.83.10.1194b172283610636647Search in Google Scholar

4. Stone EM, Lotery AJ, Munier FL, Héon E, Piguet B, Guymer RH, et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet. 1999 Jun;22(2):199-202. PubMed PMID: 10369267.10.1038/972210369267Search in Google Scholar

5. Michaelides M, Jenkins SA, Jr Brantley MA, Andrews RM, Waseem N, Luong V, et al. Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3085-97. PubMed PMID: 16799055.10.1167/iovs.05-160016799055Search in Google Scholar

6. Chen B, Gagnon M, Shahangian S, Anderson NL, Howerton DA, Boone JD. Good laboratory practices for molecular genetic testing for heritable diseases and conditions. MMWR Recomm Rep. 2009 Jun;58(RR-6):1-37; PubMed PMID: 19521335.Search in Google Scholar

7. Stone EM, Aldave AJ, Drack AV, Maccumber MW, Sheffield VC, Traboulsi E, Weleber RG. Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing. Ophthalmology. 2012 Nov;119(11):2408-10. PubMed PMID: 2944025. Epub 2012/09/01.10.1016/j.ophtha.2012.05.04722944025Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo